[An evaluation of the clinical usefulness of amifostine (YM-08310), radioprotective agent. A double-blind placebo-controlled study. 1. Head and neck tumors]

Nihon Gan Chiryo Gakkai Shi. 1985 Jun 20;20(5):984-93.
[Article in Japanese]
No abstract available

Publication types

  • Clinical Trial
  • Controlled Clinical Trial
  • English Abstract

MeSH terms

  • Adenocarcinoma / radiotherapy
  • Adolescent
  • Adult
  • Aged
  • Amifostine / therapeutic use*
  • Carcinoma, Squamous Cell / radiotherapy
  • Child
  • Clinical Trials as Topic
  • Double-Blind Method
  • Female
  • Head and Neck Neoplasms / radiotherapy*
  • Humans
  • Male
  • Middle Aged
  • Mouth Mucosa / radiation effects
  • Organothiophosphorus Compounds / therapeutic use*
  • Radiation-Protective Agents / therapeutic use*

Substances

  • Organothiophosphorus Compounds
  • Radiation-Protective Agents
  • Amifostine